For new pulmonary tuberculosis cases, which drug used in the initiation phase is stopped when the continuation phase begins?
Which of the following is NOT a type of renal damage caused by amphotericin B?
Which antimalarial drug is implicated in causing hypoglycemia?
A patient's history notes a documented severe reaction to penicillin. What other antibiotic is likely to cross-react and therefore should be avoided in this patient?
Which of the following statements about amoebicides is LEAST accurate?
Which of the following antitubercular drugs can cause psychosis?
Which of the following drugs is NOT used for chloroquine-resistant Plasmodium vivax malaria?
A patient is diagnosed with chloroquine-resistant falciparum malaria. The treating physician advises the nurse to administer quinine by IV infusion. What is the preferred IV fluid for quinine infusion?
Which of the following statements about stavudine is accurate?
Which of the following penicillins has no effect on Pseudomonas aeruginosa?
Explanation: ### Explanation In the management of new pulmonary tuberculosis (TB) cases under the **RNTCP/NTEP guidelines**, the treatment is divided into two phases: the **Intensive (Initiation) Phase** and the **Continuation Phase**. **Why Pyrazinamide is the correct answer:** The standard regimen for a new case is **2HRZE + 4HRE** (or 4HR depending on specific guidelines). * **Intensive Phase (2 months):** Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), and Ethambutol (E) are administered. * **Continuation Phase (4 months):** Only Isoniazid, Rifampicin, and Ethambutol (in some protocols) are continued. **Pyrazinamide** is stopped after the first 2 months because its primary role is to kill **slowly multiplying intracellular bacilli** (sterilizing action) in the acidic environment of macrophages. Once this initial "sterilization" is achieved, it is no longer required for the long-term elimination of dormant bacilli. **Analysis of Incorrect Options:** * **B. Isoniazid & C. Rifampicin:** These are the "backbone" of TB therapy. They are bactericidal and must be continued throughout both phases to ensure a cure and prevent relapse. * **A. Ethambutol:** In the current NTEP daily regimen, Ethambutol is often continued into the continuation phase along with H and R to prevent the development of drug resistance, especially in areas with high baseline isoniazid resistance. **High-Yield Clinical Pearls for NEET-PG:** * **Pyrazinamide** is the most hepatotoxic of the first-line drugs and can cause **hyperuricemia** (leading to gouty arthritis). * **Mechanism of Action:** Pyrazinamide is a prodrug converted to **pyrazinoic acid** by the enzyme *pyrazinamidase*. * **Site of Action:** It is most active in an **acidic pH** (intracellularly). * **Visual Side Effects:** Remember **Ethambutol** causes optic neuritis (red-green color blindness), while **Rifampicin** causes orange-colored secretions.
Explanation: Amphotericin B is notorious for its dose-dependent nephrotoxicity, which occurs via two primary mechanisms: direct toxicity to the renal tubular epithelium and induction of renal vasoconstriction. **Explanation of the Correct Option:** **C. Glomerulonephritis:** This is an inflammatory process typically involving immune complexes or direct basement membrane damage. Amphotericin B does **not** cause glomerulonephritis. Its renal damage is primarily tubular and vascular in nature, rather than glomerular inflammation. **Explanation of Incorrect Options:** * **A. Azotemia:** This is the most common manifestation. Amphotericin B causes constriction of the afferent arterioles, leading to decreased renal blood flow and GFR, which results in a rise in serum creatinine and BUN. * **B. Renal Tubular Acidosis (RTA):** Amphotericin B increases the permeability of the distal tubular membrane. This leads to a "leak" of hydrogen ions, causing **Type 1 (Distal) RTA**. * **D. Hypokalemia:** Due to increased membrane permeability in the distal tubules and collecting ducts, there is significant wasting of potassium and magnesium. This electrolyte imbalance is a hallmark side effect. **High-Yield Clinical Pearls for NEET-PG:** * **Liposomal Amphotericin B:** Developed to reduce nephrotoxicity by targeting the drug to the reticuloendothelial system rather than the kidneys. * **Saline Loading:** Pre-infusion with 1 liter of normal saline is the standard clinical practice to "wash out" the drug and minimize the risk of azotemia. * **Anemia:** Amphotericin B also causes normocytic normochromic anemia due to decreased erythropoietin production by the damaged kidneys.
Explanation: **Explanation:** **Quinine** is the correct answer because it is a potent stimulator of pancreatic beta cells [2]. It triggers the release of **insulin** (hyperinsulinemia) by blocking ATP-sensitive potassium channels, leading to significant **hypoglycemia**. This is a critical clinical concern, especially in pregnant patients and those with severe malaria, where glucose levels must be monitored closely. **Analysis of Incorrect Options:** * **Chloroquine (A):** Primarily associated with retinal toxicity (bull’s eye maculopathy) and ECG changes (prolonged QT interval) [2]. It does not typically cause hypoglycemia. * **Pyrimethamine (B):** A folate antagonist used in toxoplasmosis and malaria [1]. Its main side effects are hematological (megaloblastic anemia) due to dihydrofolate reductase inhibition. * **Primaquine (C):** Used for the radical cure of *P. vivax* and *P. ovale*. Its hallmark toxicity is **hemolysis in G6PD deficient individuals** and methemoglobinemia. **High-Yield Clinical Pearls for NEET-PG:** * **Cinchonism:** A classic triad of symptoms associated with Quinine/Quinidine toxicity: Tinnitus, Headache, and Dizziness/Blurred vision [2]. * **Blackwater Fever:** A rare but severe complication of Quinine therapy or malaria itself, characterized by massive intravascular hemolysis and hemoglobinuria. * **Drug of Choice:** While Quinine was the mainstay for severe malaria, **Artesunate** is now the preferred drug of choice due to better efficacy and a lower side-effect profile. * **Safe in Pregnancy:** Quinine is considered safe for treating malaria in the first trimester of pregnancy.
Explanation: **Explanation:** The core concept behind this question is **cross-reactivity** among beta-lactam antibiotics [1]. Penicillins and Cephalosporins both share a common **beta-lactam ring** structure [1]. In patients with a documented severe (Type I, IgE-mediated) hypersensitivity to penicillin, there is a risk of cross-reactivity with cephalosporins (historically cited at 10%, though modern studies suggest it is closer to 1-3%, particularly with first-generation agents) [2]. Due to the potential for life-threatening anaphylaxis, cephalosporins are generally avoided if the penicillin reaction was severe [2]. **Analysis of Options:** * **A. Aminoglycosides (e.g., Gentamicin):** These are chemically unrelated to beta-lactams. They inhibit protein synthesis via the 30S ribosomal subunit and do not cross-react with penicillins. * **B & D. Macrolides (Azithromycin/Erythromycin):** These are the drugs of choice for patients allergic to penicillin. They contain a macrocyclic lactone ring and inhibit the 50S subunit; they have no structural similarity to penicillins. **High-Yield NEET-PG Pearls:** * **Structural Basis:** Cross-reactivity is primarily determined by the **R1 side chain** similarity rather than the beta-lactam ring itself [2]. * **Generation Matters:** Cross-reactivity is highest with 1st-generation cephalosporins (e.g., Cephalexin) and negligible with 3rd or 4th-generation agents [2]. * **Monobactams:** **Aztreonam** is the only beta-lactam that typically does *not* cross-react with penicillins (except for a specific cross-sensitivity with Ceftazidime due to identical side chains). * **Carbapenems:** These also carry a small risk (<1%) of cross-reactivity and should be used with caution.
Explanation: **Explanation:** The treatment of amoebiasis is categorized based on the site of action: **Luminal**, **Tissue**, or **Mixed** amoebicides. **Why Option D is the correct answer (Least Accurate):** **Paromomycin** is an aminoglycoside antibiotic that is not absorbed from the gastrointestinal tract. Because it remains entirely within the gut, it acts solely as a **luminal amoebicide**. It is highly effective for asymptomatic cyst passers and for eradicating cysts following a course of tissue amoebicides, but it has **no efficacy** in extraintestinal (e.g., hepatic) amoebiasis. **Analysis of Incorrect Options:** * **Option A:** **Diloxanide furoate** is a classic luminal amoebicide. It is the drug of choice for asymptomatic intestinal colonization. * **Option B:** **Emetine/Dehydroemetine** are potent tissue amoebicides but are highly toxic. They are **cardiotoxic** (causing arrhythmias and hypotension) and **embryotoxic**, making them contraindicated in cardiac patients and during pregnancy. * **Option C:** **Metronidazole** (and Tinidazole) are rapidly absorbed from the small intestine. By the time they reach the colon, their concentration is insufficient to kill luminal cysts. Thus, they must always be followed by a luminal agent to prevent relapse. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC) for Hepatic Abscess:** Metronidazole. * **DOC for Asymptomatic Cyst Passers:** Diloxanide furoate or Paromomycin. * **Paromomycin** is also used in the treatment of **Visceral Leishmaniasis** (Kala-azar). * **Metronidazole Side Effects:** Disulfiram-like reaction with alcohol and a metallic taste in the mouth.
Explanation: **Explanation:** **Cycloserine** is a second-line antitubercular drug (Group C) that acts by inhibiting cell wall synthesis (specifically D-alanine ligase and alanine racemase). It is notorious for its **neuropsychiatric side effects**, earning it the nickname "Psych-serine." 1. **Why Cycloserine is correct:** It is a structural analogue of D-alanine and can cross the blood-brain barrier effectively. It acts as a partial agonist at the **NMDA (N-methyl-D-aspartate) receptors** in the CNS. This interference leads to a wide spectrum of CNS toxicities, including **psychosis**, depression, anxiety, seizures, and suicidal ideation. Pyridoxine (Vitamin B6) is often co-administered to mitigate some of these neurological effects. 2. **Why other options are incorrect:** * **Ofloxacin:** A fluoroquinolone that primarily causes GI upset and tendonitis. While it can rarely cause CNS stimulation (insomnia/dizziness), it is not the classic cause of drug-induced psychosis in TB therapy. * **Capreomycin:** An injectable polypeptide antibiotic. Its primary toxicities are **nephrotoxicity** and **ototoxicity** (similar to aminoglycosides). * **Rifampicin:** A first-line agent that inhibits DNA-dependent RNA polymerase. Its hallmark side effects are **hepatotoxicity** and the harmless **orange-red discoloration** of body fluids. **High-Yield Clinical Pearls for NEET-PG:** * **Contraindication:** Cycloserine is strictly contraindicated in patients with a history of epilepsy or psychiatric illness. * **Isoniazid (INH):** Can also cause peripheral neuropathy and occasionally "INH psychosis" (due to B6 deficiency), but Cycloserine is the more potent and classic trigger for psychosis in exams. * **Ethambutol:** Associated with **Optic Neuritis** (red-green color blindness). * **Pyrazinamide:** Most hepatotoxic first-line drug; causes hyperuricemia (gout).
Explanation: **Explanation:** The management of chloroquine-resistant *Plasmodium vivax* (CRPV) requires shifting from standard 4-aminoquinolines to more potent schizontocidal agents or combination therapies. **Why Fluoroquinolones are the correct answer:** While some fluoroquinolones (like Ciprofloxacin or Levofloxacin) exhibit weak anti-plasmodial activity *in vitro* by inhibiting the parasite's DNA gyrase, they are **not clinically recommended** or used for the treatment of malaria. Their efficacy is significantly lower than standard antimalarials, and using them poses a high risk of developing bacterial resistance. **Analysis of incorrect options:** * **Quinine:** This remains a traditional and effective backup for chloroquine-resistant strains. It is a rapidly acting blood schizontocide used in resistant cases, often combined with another agent to ensure complete clearance. * **Doxycycline:** This is a slow-acting blood schizontocide. In cases of chloroquine resistance, it is frequently used in combination with Quinine to enhance cure rates and prevent recrudescence. * **Primaquine:** This is essential in the treatment of *P. vivax* for **radical cure**. It targets the latent liver stages (hypnozoites) to prevent relapse. Regardless of chloroquine resistance in the blood stage, Primaquine remains a standard part of the regimen (provided the patient is not G6PD deficient). **NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC) for CRPV:** According to WHO and NVBDCP, the preferred treatment is **ACT (Artemisinin-based Combination Therapy)**, specifically Artemether + Lumefantrine or Artesunate + Sulfadoxine-Pyrimethamine (though SP resistance is a concern). * **Radical Cure:** Always check **G6PD levels** before administering Primaquine to avoid acute hemolysis. * **Tafenoquine:** A newer single-dose alternative to the 14-day Primaquine regimen for radical cure.
Explanation: Quinine is a potent stimulator of pancreatic beta cells, leading to hyperinsulinemia [2]. In patients with severe malaria, glucose consumption by the parasites and impaired hepatic gluconeogenesis already predispose the patient to hypoglycemia. Administering Quinine can trigger profound, life-threatening hypoglycemia. Therefore, it must always be administered in a glucose-containing vehicle, such as 5% Dextrose, to counteract this metabolic side effect and maintain blood glucose levels during the infusion. Quinine is primarily metabolized in the liver and excreted in the urine [1]. Quinine should never be given as an IV bolus due to the risk of fatal arrhythmias and hypotension; it must be given as a slow IV infusion over 4 hours [2]. While IV Artesunate is now the preferred first-line treatment for severe malaria (WHO guidelines), Quinine remains a high-yield alternative [3].
Explanation: Stavudine (d4T) is a **Nucleoside Reverse Transcriptase Inhibitor (NRTI)** used in the management of HIV [2, 3]. The correct answer is **B** because the hallmark dose-limiting toxicity of stavudine is **peripheral neuropathy** (neurotoxicity) [3]. 1. **Why Option B is correct:** Stavudine has a high affinity for **mitochondrial DNA polymerase-gamma** [1, 2]. By inhibiting this enzyme, it leads to mitochondrial dysfunction [1, 2]. Clinically, this manifests as painful sensory peripheral neuropathy and lipoatrophy (loss of subcutaneous fat) [3]. 2. **Why Option A is incorrect:** While many NRTIs cause cytopenias, **bone marrow suppression** is specifically the dose-limiting toxicity of **Zidovudine (AZT)**, not stavudine. 3. **Why Option C is incorrect:** Stavudine inhibits **Reverse Transcriptase** [2], not HIV Protease. Protease inhibitors (e.g., Ritonavir, Atazanavir) belong to a different class of antiretrovirals. 4. **Why Option D is incorrect:** Stavudine is a **Nucleoside** Reverse Transcriptase Inhibitor (NRTI) [2, 3]. Non-nucleoside inhibitors (NNRTIs) include drugs like Efavirenz and Nevirapine, which do not require phosphorylation to become active. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Mitochondrial Toxicity:** The "D-drugs" (**D**idanosine, **D**eoxycytidine/Zalcitabine, and **S**tavudine) are most notorious for mitochondrial toxicity, leading to neuropathy and **lactic acidosis** [1]. * **Lipoatrophy:** Stavudine is the NRTI most strongly associated with facial and limb fat loss [3]. * **Avoid Combination:** Stavudine and Zidovudine should **not** be used together because they compete for the same intracellular phosphorylation pathway (antagonistic effect) [3].
Explanation: **Explanation:** The correct answer is **Nafcillin**. **1. Why Nafcillin is the correct answer:** Nafcillin belongs to the **Penicillinase-resistant penicillins** (along with Methicillin, Oxacillin, and Cloxacillin). These drugs are specifically designed to resist degradation by staphylococcal beta-lactamase [1, 2]. Their spectrum is narrow and primarily limited to Gram-positive organisms, specifically **MSSA (Methicillin-sensitive Staphylococcus aureus)** [1]. They have **no activity** against Gram-negative bacteria like *Pseudomonas aeruginosa* because they cannot penetrate the outer membrane of these organisms [2]. **2. Analysis of incorrect options:** * **Ticarcillin & Carbenicillin (Options A & B):** These are **Carboxypenicillins**. They were the first group of "Antipseudomonal penicillins" developed specifically to treat serious infections caused by *Pseudomonas* and *Proteus* species [2]. * **Azlocillin (Option C):** This is a **Ureidopenicillin** (along with Piperacillin and Mezlocillin). These are the most potent antipseudomonal penicillins, offering superior activity against *Pseudomonas* compared to the carboxypenicillins [2]. **3. NEET-PG High-Yield Pearls:** * **Antipseudomonal Penicillins mnemonic:** "TCP" (**T**icarcillin, **C**arbenicillin, **P**iperacillin). * **Piperacillin** is currently the most commonly used antipseudomonal penicillin, often combined with the beta-lactamase inhibitor **Tazobactam** (Pip-Tazo). * **Nafcillin** is primarily excreted via the **biliary route**, making it a safe choice for patients with renal failure (no dose adjustment required). * **Interstitial nephritis** is a classic side effect associated with the penicillinase-resistant class (historically most common with Methicillin).
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free